when will retatrutide be released 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in When will Retatrutide be available

, & O'Rahilly, S

Taking Ozempic or Wegovy without a medical diagnosis just to lose weight is not an official use

As a next-generation triple-action peptide, it works by targeting GLP-1, GIP, and glucagon receptors togetherthree critical pathways in metabolism

Related Reading Frequently Asked Questions What is retatrutide and how is it different from semaglutide or tirzepatide

References: Elective perioperative management of adults taking glucagonlike peptide1 receptor agonists, glucosedependent insulinotropic peptide agonists and sodiumglucose cotransporter2 inhibitors: A multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association